Circulating N-terminal pro-B-type natriuretic peptide in fetal anemia before and after treatment

[1]  B. Stoffel‐Wagner,et al.  N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations , 2012, Clinical Research in Cardiology.

[2]  N. Uldbjerg,et al.  Parvovirus B19 infection in human pregnancy , 2011, BJOG : an international journal of obstetrics and gynaecology.

[3]  T. Tongsong,et al.  Venous Doppler studies in low-output and high-output hydrops fetalis. , 2010, American journal of obstetrics and gynecology.

[4]  B. Stoffel‐Wagner,et al.  Reference values for N-terminal pro-B-type natriuretic peptide in fetal circulation between 20 and 34 weeks of gestation. , 2010, Clinical biochemistry.

[5]  K. Thornburg,et al.  Cardiomyocyte enlargement, proliferation and maturation during chronic fetal anaemia in sheep , 2010, Experimental physiology.

[6]  J. Deprest,et al.  Methods for prenatal assessment of fetal cardiac function , 2009, Prenatal diagnosis.

[7]  W. Arzt,et al.  Amino Terminal pro B-Type Natriuretic Peptide Levels Are Elevated in the Cord Blood of Neonates With Congenital Heart Defect , 2009, Pediatric Research.

[8]  D. Oepkes,et al.  Total Blood Volume Is Maintained in Nonhydropic Fetuses with Severe Hemolytic Anemia , 2009, Fetal Diagnosis and Therapy.

[9]  Y. O. Xu-Cai,et al.  Molecular forms of natriuretic peptides in heart failure and their implications , 2009, Heart.

[10]  S. Gudmundsson,et al.  Biochemical tissue-specific injury markers of the heart and brain in postpartum cord blood. , 2009, American journal of obstetrics and gynecology.

[11]  Michael Böhm,et al.  Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.

[12]  Elisenda Eixarch,et al.  Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. , 2008, American journal of obstetrics and gynecology.

[13]  A. Jaffe,et al.  Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. , 2008, Clinical chemistry.

[14]  P. Collinson,et al.  Amino-terminal pro-B-type natriuretic peptide: analytic considerations. , 2008, The American journal of cardiology.

[15]  K. Moise The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. , 2008, American journal of obstetrics and gynecology.

[16]  Faquan Liang,et al.  Evidence for functional heterogeneity of circulating B-type natriuretic peptide. , 2007, Journal of the American College of Cardiology.

[17]  O. Vuolteenaho,et al.  Cardiovascular hemodynamics and umbilical artery N‐terminal peptide of proB‐type natriuretic peptide in human fetuses with growth restriction , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[18]  T. Scholz,et al.  Myocardial vascular and metabolic adaptations in chronically anemic fetal sheep. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  M David Tilson,et al.  The polymorphonuclear leukocyte and the abdominal aortic aneurysm: a neglected cell type and a neglected disease. , 2005, Circulation.

[20]  M. McGrath,et al.  Determinants of natriuretic peptide gene expression , 2005, Peptides.

[21]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[22]  G. Giraud,et al.  The effects of anaemia as a programming agent in the fetal heart , 2005, The Journal of physiology.

[23]  O. Vuolteenaho,et al.  Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. , 2004, Clinical chemistry.

[24]  K. Thornburg,et al.  Fetal anemia leads to augmented contractile response to hypoxic stress in adulthood. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[25]  V. Cameron,et al.  Minireview: natriuretic peptides during development of the fetal heart and circulation. , 2003, Endocrinology.

[26]  A. Baschat,et al.  Coronary artery blood flow velocities in various fetal conditions , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[27]  A. Baschat,et al.  The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[28]  S. Blackwell,et al.  Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. , 2000, The New England journal of medicine.

[29]  Giancarlo Mari,et al.  NONINVASIVE DIAGNOSIS BY DOPPLER ULTRASONOGRAPHY OF FETAL ANEMIA DUE TO MATERNAL RED-CELL ALLOIMMUNIZATION , 2000 .

[30]  K. Nicolaides,et al.  Fetal Venous, Arterial and Intracardiac Blood Flows in Red Blood Cell Isoimmunization , 1995, Obstetrics and gynecology.

[31]  Y. O. Xu-Cai,et al.  failure and their implications Molecular forms of natriuretic peptides in heart , 2010 .

[32]  L. R. Potter,et al.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. , 2009, Handbook of experimental pharmacology.

[33]  D. Paladini,et al.  Cardiac troponin T and amino-terminal pro-natriuretic peptide concentrations in fetuses in the second trimester and in healthy neonates , 2006, Clinical chemistry and laboratory medicine.

[34]  M. Emdin,et al.  Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. , 2004, Clinical chemistry.